Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
J Gynecol Obstet Biol Reprod (Paris) ; 37(5): 457-62, 2008 Sep.
Artigo em Francês | MEDLINE | ID: mdl-18565690

RESUMO

OBJECTIVES: Positive and differential diagnoses of mesenchymal tumors of the uterus may be sometimes problematic. The purpose of this study was to evaluate the utility of a panel of antibodies in this diagnosis. MATERIALS AND METHODS: The expression of AML, desmin, h-caldesmon and CD10 was studied in nine endometrial stromal sarcomas (SSE), two leiomyosarcomas (LMS) and 10 highly-cellular leiomyoma (HCL). RESULTS: AML positivity was found in five SSE, in all HCL and in only one LMS. Desmin expression was found in two SSE, in all HCL and LMS. H-caldesmon was negative in all SSE, positive in all HCL and in one case of LMS. CD10 was expressed in two-third of SSE. However, neither HCL nor LMS was marqued. CONCLUSION: CD10 is the most specific antibody of SSE. It seems to have the best value in the diagnosis of mesenchymal tumors in association with desmin and h-caldesmon, specific markers of smooth-muscle differentiation.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias do Endométrio/diagnóstico , Sarcoma do Estroma Endometrial/diagnóstico , Actinas/análise , Proteínas de Ligação a Calmodulina/análise , Desmina/análise , Diagnóstico Diferencial , Neoplasias do Endométrio/química , Feminino , Humanos , Imuno-Histoquímica/métodos , Leiomioma/diagnóstico , Leiomiossarcoma/diagnóstico , Neprilisina/análise , Estudos Retrospectivos , Sarcoma do Estroma Endometrial/química , Neoplasias Uterinas/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA